Veteran Marijuana Advocate Steve Fox Leaves NCIA To Join Upstart MJ Trade Group

Longtime marijuana advocate Steve Fox has left the National Cannabis Industry Association, which he co-founded, to join the upstart Cannabis Trade Federation to promote federal MJ reform.

“It is a larger lobbying team at CTF with a lot of reach into a lot of different offices,” Fox told Marijuana Business Daily.

“And, from the perspective of someone who’s been trying to change federal laws actively since 2002, the opportunity to work with so many people to try to end this battle was too good … to turn down.”

CTF recently announced it was hiring 15 Washington DC-based lobbyists to work on passing the States Act, which would exempt cannabis businesses operating in accordance with state law from the federal Controlled Substances Act.

“We’re putting a full-court press on to try to get that passed during this session,” Fox said.

As a strategic adviser, Fox will be working as a consultant for CTF based in Washington DC.

CTF was formed in April 2018 through the merger of the New Federalism Fund and the American Trade Association of Cannabis and Hemp.

Fox co-founded NCIA in 2010 and worked with the group for eight years. He took an expanded role eight months ago as a strategic adviser to NCIA’s DC efforts.

“This is isn’t any reflection of my feelings about NCIA as an organization or anything like that,” Fox said of his move to CTF. “I completely value my time that I spent with the organization.”

Original Article Source: https://mjbizdaily.com/veteran-marijuana-advocate-steve-fox-leaves-ncia-to-join-upstart-mj-trade-group/

Comments

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

Norma Pence

Search This Blog